Received Apr 20, 2026
Reports are unverified and do not show that a vaccine caused an event. Full disclaimer
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| TDAP | TDAP (BOOSTRIX) | GLAXOSMITHKLINE BIOLOGICALS | UNK | N4935 | — |
Boostrix was administered to patient after above temperature excursion; This non-serious case was reported by a nurse via call center representative and described the occurrence of incorrect storage of drug in a 23-year-old female patient who received DTPa (Reduced antigen) (Boostrix) (batch number N4935, expiry date 19-MAY-2028) for prophylaxis. On 09-APR-2026, the patient received Boostrix. On an unknown date, an unknown time after receiving Boostrix, the patient experienced incorrect storage of drug (Verbatim: Boostrix was administered to patient after above temperature excursion). The outcome of the incorrect storage of drug was not applicable. Additional Information: GSK receipt date: 10-APR-2026 The Boostrix was administered to the patient after an above-temperature excursion occurred on 08-APR-2026. The fridge lock was being repaired when the temperature went out of range, reaching 60.3 degree F for 1 hour and 50 minutes.; Sender's Comments: US-GSK-US2026049988:Same reporter